A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/58 (2006.01) A61K 31/138 (2006.01) A61K 31/381 (2006.01) A61K 31/567 (2006.01) A61P 5/24 (2006.01) A61P 15/00 (2006.01)
Patent
CA 2268211
The treatment of an estrogen sensitive condition by the administration of a selective estrogen receptor modulator is improved by additionally administering a progestationally active compound to the recipient. The additional agent can express both progestational and androgenic activity or an androgenically active material can be employed, if desired. Additionally, clomiphene in an array of isomeric ratios (EN:ZU) can be used alone for prevention of osteoporosis, maintenance of a healthful blood lipid profile, and prevention of breast tumors, or to sustain amenorrhea.
Eastern Virginia Medical School
Mccarthy Tetrault Llp
Medical College Of Hampton Roads
LandOfFree
Control of selective estrogen receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Control of selective estrogen receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Control of selective estrogen receptor modulators will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1530636